Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-016097
Filing Date
2022-04-27
Accepted
2022-04-27 16:35:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A lyra-defa14a_20220616.htm DEFA14A 13712
2 GRAPHIC gqidinxh3iav000002.jpg GRAPHIC 668424
3 GRAPHIC gqidinxh3iav000001.jpg GRAPHIC 1093588
  Complete submission text file 0001564590-22-016097.txt   2441581
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39273 | Film No.: 22860285
SIC: 3841 Surgical & Medical Instruments & Apparatus